Exhibit 99.1

Cadre Holdings Reports Third Quarter 2022 Financial Results

Achieved Net Income and Adjusted EBITDA Growth; Expanded Adjusted EBITDA Margin

Exceeded Pricing Growth Target Above Inflation

Reaffirms 2022 Full-Year Guidance

JACKSONVILLE, Fla., November 10, 2022 – Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced today its consolidated operating results for the three and nine months ended September 30, 2022.

Third Quarter and Nine-Month 2022 Highlights

●

Net sales of $111.6 million for the third quarter; net sales of $334.2 million for the nine months ended September 30, 2022

●

Gross profit margin of 39.2% for the third quarter; gross profit margin of 38.0% for the nine months ended September 30, 2022

●

Net income of $4.9 million, or $0.13 per diluted share, for the third quarter; net loss of $0.8 million, or $0.02 per diluted share, for the nine months ended September 30, 2022

●

Adjusted EBITDA of $20.7 million for the third quarter; Adjusted EBITDA of $53.3 million for the nine months ended September 30, 2022

●

Adjusted EBITDA margin of 18.6% for the third quarter; Adjusted EBITDA margin of 16.0% for the nine months ended September 30, 2022

●

Adjusted EBITDA conversion of 97% for the third quarter; Adjusted EBITDA conversion of 94% for the nine months ended September 30, 2022

●

Declared quarterly cash dividend of $0.08 per share in October 2022

“We are pleased with Cadre’s significant progress in our first 12 months as a public company, delivering on strategic objectives and capitalizing on the attractive long-term tailwinds driving demand for our mission-critical safety and survivability equipment,” said Warren Kanders, CEO and Chairman. “Despite persistent supply chain disruptions and inflationary pressures, Cadre has continued to benefit from its resilient operating model and entrenched positions in law enforcement, first responder, and military markets. During the third quarter, we generated year-over-year and sequential improvements in net income and adjusted EBITDA. Importantly, our product portfolio mix began to improve in Q3 as anticipated, and adjusted EBITDA margin improved by 300 basis points versus Q2.”

“Cadre once again exceeded our 1% pricing growth target above inflation, helping to drive outstanding adjusted EBITDA conversion above the high-end of our guidance range. Based on our continued strong cash flow generation, we remain well positioned to capitalize on a robust M&A pipeline, complementing our core organic growth initiatives. Building on our two accretive acquisitions year-to-date, we continue actively pursuing attractive acquisitions and remain steadfast in our focus on high margin companies with leading market positions and strong recurring revenues and cash flows for the benefit of shareholders.”

Third Quarter and Nine-Month 2022 Operating Results

For the quarter ended September 30, 2022, Cadre generated net sales of $111.6 million, as compared to $98.7 million for the quarter ended September 30, 2021. The increase in the product segment was primarily the result of recent acquisitions and armor volume partially offset by a large contractual armor order that was fulfilled in the prior year, and in our distribution segment, the increase was driven by agency demand for hard goods.

For the nine months ended September 30, 2022, Cadre generated net sales of $334.2 million, as compared to $323.8 million for the prior year period, mainly driven by distribution volume, and recent acquisitions, offset by prior year US Federal and crowd control shipments.

For the quarter ended September 30, 2022, Cadre generated gross profit of $43.7 million, as compared to $39.3 million for the quarter ended September 30, 2021. For the nine months ended September 30, 2022, Cadre generated gross profit of $127.2 million, as compared to $131.5 million for the prior year period.

Gross profit margin was 39.2% for the quarter ended September 30, 2022, as compared to 39.8% for the quarter ended September 30, 2021. Gross profit margin was 38.0% for the nine months ended September 30, 2022, as compared to 40.6% for the prior year period, mainly driven by 91 basis points from the amortization of inventory step-up recorded as part of the recent acquisitions and less favorable mix, partially offset by pricing in excess of material inflation.

Net income was $4.9 million for the quarter ended September 30, 2022, as compared to a net loss of $5.3 million for the quarter ended September 30, 2021. The increase resulted primarily from improved revenue and the loss on extinguishment of debt related to the August 2021 debt refinance.

Net loss was $0.8 million for the nine months ended September 30, 2022, as compared to net income of $8.4 million for the prior year period, primarily as a result of stock-based compensation expense and unfavorable product and portfolio mix.

Cadre generated $20.7 million of Adjusted EBITDA for the quarter ended September 30, 2022, as compared to $15.4 million for the quarter ended September 30, 2021. Adjusted EBITDA margin was 18.6% for the quarter ended September 30, 2022, as compared to 15.6% for the prior year period.

Cadre generated $53.3 million of Adjusted EBITDA for the nine months ended September 30, 2022, as compared to $56.1 million for the prior year period. Adjusted EBITDA margin was 16.0% for the nine months ended September 30, 2022, as compared to 17.3% for the prior year period.

Product segment gross margin was 41.6% and 40.2% for the third quarter and first nine months of 2022, respectively, compared to 40.5% and 41.6% for the respective prior year periods.

Distribution segment gross margin was 19.8% and 20.9% for the third quarter and first nine months of 2022, respectively, compared to 24.6% and 25.2% for the respective prior year periods.

Liquidity, Cash Flows and Capital Allocation

●

Cash and cash equivalents increased by $2.5 million from $33.9 million as of December 31, 2021 to $36.4 million as of September 30, 2022.

●

Total debt decreased by $6.6 million from $159.7 million as of December 31, 2021, to $153.1 million as of September 30, 2022.

●

Net debt (total debt net of cash and cash equivalents) decreased by $9.0 million from $125.8 million as of December 31, 2021, to $116.8 million as of September 30, 2022.

●

Capital expenditures totaled $0.7 million for the third quarter and $3.2 million for the nine months ended September 30, 2022, compared with $0.7 million for the third quarter and $2.2 million for the nine months ended September 30, 2021.

Dividend

On October 20, 2022, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, or $0.32 per share on an annualized basis. Cadre's dividend payment will be made on November 14, 2022, to shareholders of record as of the close of business on the record date of November 1, 2022. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

2022 Outlook

For the full year 2022, Cadre expects to generate net sales in the range of $444.0 million to $452.0 million and Adjusted EBITDA in the range of $72.5 million and $77.5 million. Cadre expects Adjusted EBITDA conversion in the range of 92-95% for the full year.

Conference Call

Cadre management will host a conference call on Thursday, November 10, 2022, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (888)-510-2553 and the dial-in number for international callers is 646-960-0473. The access code for all callers is 1410384. A live webcast will also be available on the Company’s website at https://www.cadre-holdings.com/.

A replay of the call will be available through November 24, 2022. To access the replay, please dial 800-770-2030 in the U.S. or +1-647-362-9199 if outside the U.S., and then enter the access code 1410384.

About Cadre

Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

Use of Non-GAAP Measures

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin, (iv) adjusted EBITDA conversion rate and (v) LTM adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period-over-period operating performance, and thereby enhances the user’s overall understanding of the Company’s current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company’s reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

Forward-Looking Statements

Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation, changes to global, social and political economic conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, logistical challenges related to disruptions and delays, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doing business in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company’s financial results are more fully described from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

Contact:

Gray Hudkins

Cadre Holdings, Inc.

203-550-7148

[email protected]

Investor Relations:

The IGB Group

Leon Berman / Matt Berkowitz

212-477-8438 / 212-227-7098

[email protected] / [email protected]

Media Contact:

Jonathan Keehner / Andrew Siegel

Joele Frank, Wilkinson Brimmer Katcher

212-355-4449

CADRE HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)


	September 30, 2022		December 31, 2021
Assets
Current assets
Cash and cash equivalents	$	36,350	$	33,857
Accounts receivable, net of allowance for doubtful accounts of $774 and $645, respectively		55,759		48,344
Inventories		79,246		63,978
Prepaid expenses		8,740		10,353
Other current assets		7,493		3,171
Assets held for sale		225		278
Total current assets		187,813		159,981
Property and equipment, net of accumulated depreciation and amortization of $41,478 and $37,171, respectively		45,671		33,053
Deferred tax assets, net		5,350		7,059
Intangible assets, net		51,518		42,415
Goodwill		77,196		66,262
Other assets		7,631		3,026
Total assets	$	375,179	$	311,796

Liabilities, Mezzanine Equity and Shareholders' Equity
Current liabilities
Accounts payable	$	24,523	$	19,328
Accrued liabilities		35,515		40,736
Income tax payable		957		1,255
Liabilities held for sale		91		128
Current portion of long-term debt		13,285		13,174
Total current liabilities		74,371		74,621
Long-term debt		139,818		146,516
Deferred tax liabilities		3,526		1,297
Other liabilities		904		722
Total liabilities		218,619		223,156

Mezzanine equity
Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 2021)		—		—

Shareholders' equity
Common stock ($0.0001 par value, 190,000,000 shares authorized, 37,332,271 and 34,383,350 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively)		4		3
Additional paid-in capital		203,754		127,606
Accumulated other comprehensive loss		(846)		(1,917)
Accumulated deficit		(46,352)		(37,052)
Total shareholders’ equity		156,560		88,640
Total liabilities, mezzanine equity and shareholders' equity	$	375,179	$	311,796

CADRE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except share and per share amounts)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net sales	$	111,554	$	98,654	$	334,192	$	323,751
Cost of goods sold		67,814		59,346		207,042		192,256
Gross profit		43,740		39,308		127,150		131,495
Operating expenses
Selling, general and administrative		31,732		27,673		118,431		87,168
Restructuring and transaction costs		1,578		(49)		3,380		1,491
Related party expense		112		142		1,346		437
Total operating expenses		33,422		27,766		123,157		89,096
Operating income		10,318		11,542		3,993		42,399
Other expense
Interest expense		(1,567)		(3,464)		(4,496)		(14,129)
Loss on extinguishment of debt		—		(15,155)		—		(15,155)
Other expense, net		(1,851)		(352)		(2,812)		(881)
Total other expense, net		(3,418)		(18,971)		(7,308)		(30,165)
Income (loss) before provision for income taxes		6,900		(7,429)		(3,315)		12,234
(Provision) benefit for income taxes		(1,959)		2,123		2,536		(3,861)
Net income (loss)	$	4,941	$	(5,306)	$	(779)	$	8,373

Net income (loss) per share:
Basic	$	0.13	$	(0.19)	$	(0.02)	$	0.30
Diluted	$	0.13	$	(0.19)	$	(0.02)	$	0.30
Weighted average shares outstanding:
Basic		37,289,880		27,483,350		35,697,891		27,483,350
Diluted		37,747,613		27,483,350		35,697,891		27,483,350

CADRE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)


	Nine Months Ended September 30,
	2022		2021
Cash Flows From Operating Activities:
Net (loss) income	$	(779)	$	8,373
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization		11,319		10,426
Amortization of original issue discount and debt issue costs		554		2,483
Amortization of inventory step-up		3,055		—
Loss on extinguishment of debt		—		15,155
Deferred income taxes		(2,755)		1,533
Stock-based compensation		28,988		—
Provision for (recoveries from) losses on accounts receivable		245		(254)
Foreign exchange loss		3,006		45
Changes in operating assets and liabilities, net of impact of acquisitions:
Accounts receivable		(3,271)		1,549
Inventories		(7,187)		(10,261)
Prepaid expenses and other assets		986		(4,642)
Accounts payable and other liabilities		(4,660)		6,582
Net cash provided by operating activities		29,501		30,989
Cash Flows From Investing Activities:
Purchase of property and equipment		(2,938)		(2,225)
Business acquisitions, net of cash acquired		(55,039)		—
Net cash used in investing activities		(57,977)		(2,225)
Cash Flows From Financing Activities:
Proceeds from revolving credit facilities		43,000		248,000
Principal payments on revolving credit facilities		(43,000)		(223,132)
Proceeds from term loans		—		198,735
Principal payments on term loans		(7,514)		(224,547)
Proceeds from insurance premium financing		3,989		4,269
Principal payments on insurance premium financing		(3,878)		(2,611)
Payment of capital leases		(26)		(32)
Payments for debt issuance costs		—		(2,830)
Payments on extinguishment of debt		—		(4,215)
Taxes paid in connection with employee stock transactions		(6,216)		—
Proceeds from secondary offering, net of underwriter discounts		56,329		—
Deferred offering costs		(2,953)		—
Dividends distributed		(8,521)		(9,996)
Net cash provided by (used in) financing activities		31,210		(16,359)
Effect of foreign exchange rates on cash and cash equivalents		(241)		(3)
Change in cash and cash equivalents		2,493		12,402
Cash and cash equivalents, beginning of period		33,857		2,873
Cash and cash equivalents, end of period	$	36,350	$	15,275
Supplemental Disclosure of Cash Flows Information:
Cash paid for income taxes, net	$	710	$	695
Cash paid for interest	$	3,860	$	8,524
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Accruals and accounts payable for capital expenditures	$	272	$	—

CADRE HOLDINGS, INC.

SEGMENT INFORMATION

(Unaudited)

(In thousands)


	Nine months ended September 30, 2022
					Reconciling
	Products		Distribution		Items⁽¹⁾		Total
Net sales	$	277,941	$	73,836	$	(17,585)	$	334,192
Cost of goods sold		166,192	$	58,437	$	(17,587)		207,042
Gross profit	$	111,749	$	15,399	$	2	$	127,150


	Nine months ended September 30, 2021
					Reconciling
	Products		Distribution		Items⁽¹⁾		Total
Net sales	$	274,039	$	69,086	$	(19,374)	$	323,751
Cost of goods sold		159,924		51,696		(19,364)		192,256
Gross profit	$	114,115	$	17,390	$	(10)	$	131,495

(1)	Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

CADRE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)


	Year ended			Three Months			Three Months Ended						Nine Months Ended						Last Twelve
	December 31,			Ended June 30,			September 30,						September 30,						Months
	2021			2022			2022			2021			2022			2021			September 30, 2022
Net income (loss)	$	12,661		$	4,445		$	4,941		$	(5,306)		$	(779)		$	8,373		$	3,509
Add back:
Depreciation and amortization		13,718			3,836			3,939			3,406			11,319			10,426			14,611
Interest expense		16,425			1,439			1,567			3,464			4,496			14,129			6,792
Provision (benefit) for income taxes		6,531			1,517			1,959			(2,123)			(2,536)			3,861			134
EBITDA	$	49,335		$	11,237		$	12,406		$	(559)		$	12,500		$	36,789		$	25,046
Add back:
Restructuring and transaction costs⁽¹⁾		3,430			2,203			1,578			(49)			4,380			1,491			6,319
Loss on extinguishment of debt⁽²⁾		15,155			—			—			15,155			—			15,155			—
Other expense, net⁽³⁾		947			756			1,851			352			2,812			881			2,878
Stock-based compensation expense⁽⁴⁾		355			2,818			2,820			—			29,361			—			29,716
Stock-based compensation payroll tax expense⁽⁵⁾		—			7			—			—			305			—			305
LTIP bonus⁽⁶⁾		2,162			174			375			524			933			1,804			1,291
Amortization of inventory step-up⁽⁷⁾		—			1,191			1,711			—			3,055			—			3,055
Adjusted EBITDA	$	71,384		$	18,386		$	20,741		$	15,423		$	53,346		$	56,120		$	68,610
Less: Capital expenditures		(3,029)			(1,421)			(720)			(719)			(3,210)			(2,225)			(4,014)
Adjusted EBITDA less capital expenditures	$	68,355		$	16,965		$	20,021		$	14,704		$	50,136		$	53,895		$	64,596
Adjusted EBITDA conversion rate⁽⁸⁾		96	%		92	%		97	%		95	%		94	%		96	%		94	%
Adjusted EBITDA margin⁽⁹⁾		16.7	%		15.6	%		18.6	%		15.6	%		16.0	%		17.3	%

(1)

Reflects the “Restructuring and transaction costs” line item on our consolidated statement of operations, which primarily includes transaction costs composed of legal and consulting fees, and $1.0 million paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, for services related to the acquisition of Cyalume, which is included in related party expense in the Company’s consolidated statements of operations and comprehensive income (loss).

(2)	Reflects losses incurred in connection with the August 2021 debt refinance.

(3)	Reflects the “Other expense, net” line item on our consolidated statement of operations. For the three and six months ended June 30, 2022 and 2021, other expense, net primarily includes losses on foreign currency transactions.

(4)	Reflects compensation expense related to equity and liability classified stock-based compensation plans.

(5)	Reflects payroll taxes associated with vested stock-based compensation awards.

(6)	Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

(7)	Reflects amortization expense related to the step-up inventory adjustment recorded as part of the recent acquisitions.

(8)	Reflects (Adjusted EBITDA less capital expenditures) / Adjusted EBITDA.

(9)	Reflects Adjusted EBITDA / Net Sales for the relevant periods.

Exhibit 99.2

THIRD QUARTER 2022

2 FORWARD - LOOKING STATEMENTS Except for historical information, certain matters discussed in this presentation may be forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward - looking statements include but are not limited to all projections and anticipated levels of future performance. Forward - looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward - looking statements, including without limitation, changes to global economic, social and political conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, logistical challenges related to disruptions and delays, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doin g business in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company’s financial results are more fully described from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10 - K, Quarterly Reports on Form 10 - Q, and Current Reports on Form 8 - K. All forward - looking statements included in this presentation are based upon information available to the Company as of the date of this presentation, and speak only as of the date hereof. We assume no obligation to update any forward - looking statements to reflect events or circumstances after the date of this presentation .. 2

TODAY’S PRESENTERS 3 BRAD WILLIAMS President BLAINE BROWERS Chief Financial Officer WARREN KANDERS Chief Executive Officer and Chairman of the Board

4 AGENDA • Q3 Review • Business Overview • Financial Summary • Full Year Outlook • Conclusion and Q&A

5 CONTINUED EXECUTION IN Q3 5 Cadre continues to deliver on strategic objectives in a challenging supply chain and inflationary environment Pricing Growth: ✓ Exceeded 1% target above material inflation Adjusted EBITDA Conversion: 1 ✓ Generated Adj. EBITDA conversion of 97% in Q3, above the high end of guidance range Q3 Mix: ✓ Higher Duty Gear shipments and improved product mix as expected Orders Backlog: ✓ Maintained strong orders backlog of $125.2 million as of September 30, 2022 Healthy M&A Funnel: ✓ Continue to actively evaluate robust pipeline of opportunities Returned Capital to Shareholders: ✓ Declared fifth consecutive quarterly dividend of $0.08 Commentary: 1. Adj. EBITDA conversion (%) defined as (Adj. EBITDA – capital expenditure) / Adj. EBITDA. Adjusted EBITDA is a non - GAAP financial measure. See slide 19 for definitions and reconciliations to the nearest GAAP measures

6 MACRO TAILWINDS SUPPORT LONG TERM SUSTAINABLE GROWTH OPPORTUNITY Two - thirds of all NATO countries spend less than 2% of GDP targets on defense and security Amidst current geopolitical turmoil, European leaders have advocated for significant increases in defense budgets Police protection expenditures have continued to trend upward even during previous financial and industrial recessions Major US cities continue to increase police budgets The American Rescue Plan provides $350 billion to hire more police

7 7 • Spend per officer increasing but police departments still struggling to fill open positions • Amid continued war in Ukraine, uptick in inquiries, which have resulted in small orders • Anticipate larger opportunities to provide safety and survivability equipment as conflict continues • Continuing to experience extended lead times with fabrics, electronic components and various raw materials • Seeing stabilized run rate for holster demand North American Law Enforcement Geopolitical Landscape Supply Chain Consumer LATEST MARKET TRENDS

8 20 20 13 CADRE'S KEY M&A CRITERIA Niche market No large - cap competition Leading market position Cost structure where material > labor Leading a nd d efensible technology High cost of substitution Mission - critical to customer Recurring revenue profile Asset - light Business Financial Market Strong brand recognition Attractive ROIC Resiliency through market c ycles CADRE'S KEY M&A CRITERIA 8

THIRD QUARTER 2022 FINANCIAL PERFORMANCE Q3 2022 Q2 2022 Q3 2021 NET SALES $111.6M $118.2M $98.7M GROSS MARGIN 39.2% 36.6% 39.8% NET INCOME (LOSS) $4.9M / $0.13 per diluted share $4.4M / $0.12 per diluted share ($5.3M) / ($0.19) per diluted share ADJUSTED EBITDA 1 $20.7M $18.4M $15.4M ADJUSTED EBITDA MARGIN 1 18.6% 15.6% 15.6% ADJUSTED EBITDA CONVERSION 1 97% 92% 95% 1. Non - GAAP financial measures. See slide 19 for definitions and reconciliations to the nearest GAAP measures • Achieved pricing growth that exceeded target and generated strong gross margin and adjusted EBITDA conversion • Increased gross margin, net income, adjusted EBITDA, and adjusted EBITDA margin from Q2 to Q3 9

10 Net Sales / Adj. EBITDA Full Year Guidance for Net Sales / Adj. EBITDA NET SALES AND ADJUSTED EBITDA NET SALES ($MM) $427.3M $334.2M YTD 2022 FY 2022 Guidance Range $444M to $452M 2021 2022 YTD % Y/Y GROWTH 4.8 % at Guidance Midpoint ADJ. EBITDA 1 ($MM) $71.4M $53.3M YTD 2022 FY 2022 Guidance Range $72.5M to $77.5M 2021 2022 YTD % Y/Y GROWTH 5.0 % at Guidance Midpoint 1. A non - GAAP financial measure. See slide 19 for definitions and reconciliations to the nearest GAAP measures

11 Q3 2022 CAPITAL STRUCTURE 1. Non - GAAP financial measures. See slide 19 for definitions and reconciliations to the nearest GAAP measures September 30, 2022 (in thousands) Cash and cash equivalents $ 36,350 Debt: Revolver $ — Current portion of long - term debt 13,285 Long - term debt 141,530 Capitalized discount/issuance costs (1,712) Total debt, net $ 153,103 Net debt (Total debt net of cash) $ 116,753 Total debt / LTM Adj. EBITDA (1) 2.2 Net debt / LTM Adj. EBITDA (1) 1.7 LTM Adj. EBITDA (1) $ 68,610

12 REAFFIRM 2022 MANAGEMENT OUTLOOK 2022 GUIDANCE NET SALES $444M to $452M Adj. EBITDA $72.5M to $77.5M Adj. EBITDA Conversion 92% to 95% 1. A non - GAAP financial measure. See slide 19 for definitions and reconciliations to the nearest GAAP measures

CONCLUSION 13 Accelerate Organic Revenue Growth Pursue M&A Opportunities Continuously Improve Gross and Adj. EBITDA Margins

14 APPENDIX

15 BALANCE SHEET 15 UNAUDITED (IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS) September 30, 2022 December 31, 2021 Assets Current assets Cash and cash equivalents $ 36,350 $ 33,857 Accounts receivable, net of allowance for doubtful accounts of $774 and $645, respectively 55,759 48,344 Inventories 79,246 63,978 Prepaid expenses 8,740 10,353 Other current assets 7,493 3,171 Assets held for sale 225 278 Total current assets 187,813 159,981 Property and equipment, net of accumulated depreciation and amortization of $41,478 and $37,171, respectively 45,671 33,053 Deferred tax assets, net 5,350 7,059 Intangible assets, net 51,518 42,415 Goodwill 77,196 66,262 Other assets 7,631 3,026 Total assets $ 375,179 $ 311,796 Liabilities, Mezzanine Equity and Shareholders' Equity Current liabilities Accounts payable $ 24,523 $ 19,328 Accrued liabilities 35,515 40,736 Income tax payable 957 1,255 Liabilities held for sale 91 128 Current portion of long - term debt 13,285 13,174 Total current liabilities 74,371 74,621 Long - term debt 139,818 146,516 Deferred tax liabilities 3,526 1,297 Other liabilities 904 722 Total liabilities 218,619 223,156 Mezzanine equity Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 2021) — — Shareholders' equity Common stock ($0.0001 par value, 190,000,000 shares authorized, 37,332,271 and 34,383,350 shares issued and outstanding as of Se ptember 30, 2022 and December 31, 2021, respectively) 4 3 Additional paid - in capital 203,754 127,606 Accumulated other comprehensive loss (846) (1,917) Accumulated deficit (46,352) (37,052) Total shareholders’ equity 156,560 88,640 Total liabilities, mezzanine equity and shareholders' equity $ 375,179 $ 311,796

16 STATEMENT OF OPERATIONS 16 UNAUDITED (IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS) Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Net sales $ 111,554 $ 98,654 $ 334,192 $ 323,751 Cost of goods sold 67,814 59,346 207,042 192,256 Gross profit 43,740 39,308 127,150 131,495 Operating expenses Selling, general and administrative 31,732 27,673 118,431 87,168 Restructuring and transaction costs 1,578 (49) 3,380 1,491 Related party expense 112 142 1,346 437 Total operating expenses 33,422 27,766 123,157 89,096 Operating income 10,318 11,542 3,993 42,399 Other expense Interest expense (1,567) (3,464) (4,496) (14,129) Loss on extinguishment of debt — (15,155) — (15,155) Other expense, net (1,851) (352) (2,812) (881) Total other expense, net (3,418) (18,971) (7,308) (30,165) Income (loss) before provision for income taxes 6,900 (7,429) (3,315) 12,234 (Provision) benefit for income taxes (1,959) 2,123 2,536 (3,861) Net income (loss) $ 4,941 $ (5,306) $ (779) $ 8,373 Net income (loss) per share: Basic $ 0.13 $ (0.19) $ (0.02) $ 0.30 Diluted $ 0.13 $ (0.19) $ (0.02) $ 0.30 Weighted average shares outstanding: Basic 37,289,880 27,483,350 35,697,891 27,483,350 Diluted 37,747,613 27,483,350 35,697,891 27,483,350

17 STATEMENT OF CASH FLOWS 17 UNAUDITED (IN THOUSANDS) Continued on next slide Nine Months Ended September 30, 2022 2021 Cash Flows From Operating Activities: Net (loss) income $ (779) $ 8,373 Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation and amortization 11,319 10,426 Amortization of original issue discount and debt issue costs 554 2,483 Amortization of inventory step - up 3,055 — Loss on extinguishment of debt — 15,155 Deferred income taxes (2,755) 1,533 Stock - based compensation 28,988 — Provision for (recoveries from) losses on accounts receivable 245 (254) Foreign exchange loss 3,006 45 Changes in operating assets and liabilities, net of impact of acquisitions: Accounts receivable (3,271) 1,549 Inventories (7,187) (10,261) Prepaid expenses and other assets 986 (4,642) Accounts payable and other liabilities (4,660) 6,582 Net cash provided by operating activities 29,501 30,989 Cash Flows From Investing Activities: Purchase of property and equipment (2,938) (2,225) Business acquisitions, net of cash acquired (55,039) — Net cash used in investing activities (57,977) (2,225)

18 STATEMENT OF CASH FLOWS - CONTINUED 18 UNAUDITED (IN THOUSANDS) Nine Months Ended September 30, 2022 2021 Cash Flows From Financing Activities: Proceeds from revolving credit facilities 43,000 248,000 Principal payments on revolving credit facilities (43,000) (223,132) Proceeds from term loans — 198,735 Principal payments on term loans (7,514) (224,547) Proceeds from insurance premium financing 3,989 4,269 Principal payments on insurance premium financing (3,878) (2,611) Payment of capital leases (26) (32) Payments for debt issuance costs — (2,830) Payments on extinguishment of debt — (4,215) Taxes paid in connection with employee stock transactions (6,216) — Proceeds from secondary offering, net of underwriter discounts 56,329 — Deferred offering costs (2,953) — Dividends distributed (8,521) (9,996) Net cash provided by (used in) financing activities 31,210 (16,359) Effect of foreign exchange rates on cash and cash equivalents (241) (3) Change in cash and cash equivalents 2,493 12,402 Cash and cash equivalents, beginning of period 33,857 2,873 Cash and cash equivalents, end of period $ 36,350 $ 15,275 Supplemental Disclosure of Cash Flows Information: Cash paid for income taxes, net $ 710 $ 695 Cash paid for interest $ 3,860 $ 8,524 Supplemental Disclosure of Non - Cash Investing and Financing Activities: Accruals and accounts payable for capital expenditures $ 272 $ —

19 1. Reflects the “Restructuring and transaction costs” line item on our consolidated statement of operations, which primarily inc lud es transaction costs composed of legal and consulting fees, and $1.0 million paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, for services related to the acquisition of Cyalume , which is included in related party expense in the Company’s consolidated statements of operations and comprehensive income (lo ss). 2. Reflects losses incurred in connection with the August 2021 debt refinancing. 3. Reflects the “Other expense, net” line item on our consolidated statement of operations. For the three and nine months ended Sep tember 30, 2022 and 2021, other expense, net primarily includes losses on foreign currency transactions. 4. Reflects compensation expense related to equity and liability classified stock - based compensation plans. 5. Reflects payroll taxes associated with vested stock - based compensation awards. 6. Reflects the cost of a cash - based long - term incentive plan awarded to employees that vests over three years. 7. Reflects amortization expense related to the step - up inventory adjustment recorded as part of the recent acquisitions. 8. Reflects (Adjusted EBITDA less capital expenditures) / Adjusted EBITDA. 9. Reflects Adjusted EBITDA / Net Sales for the relevant periods. 19 (IN THOUSANDS) NON - GAAP RECONCILIATION Year ended Three Months Three Months Ended Nine Months Ended LTM December 31, Ended June 30, September 30, September 30, September 30 2021 2022 2022 2021 2022 2021 2022 Net income (loss) $ 12,661 $ 4,445 $ 4,941 $ (5,306) $ (779) $ 8,373 $ 3,509 Add back: Depreciation and amortization 13,718 3,836 3,939 3,406 11,319 10,426 14,611 Interest expense 16,425 1,439 1,567 3,464 4,496 14,129 6,792 Provision (benefit) for income taxes 6,531 1,517 1,959 (2,123) (2,536) 3,861 134 EBITDA 49,335 $ 11,237 $ 12,406 $ (559) $ 12,500 $ 36,789 $ 25,046 Add back: Restructuring and transaction costs (1) 3,430 2,205 1,578 (49) 4,380 1,491 6,319 Loss on extinguishment of debt (2) 15,155 — — 15,155 — 15,155 — Other expense, net (3) 947 756 1,851 352 2,812 881 2,878 Stock - based compensation expense (4) 355 2,818 2,820 — 29,361 — 29,716 Stock - based compensation payroll tax expense (5) — 7 — — 305 — 305 LTIP bonus (6) 2,162 174 375 524 933 1,804 1,291 Amortization of inventory step - up (7) — 1,191 1,711 — 3,055 — 3,055 Adjusted EBITDA 71,384 $ 18,386 $ 20,741 $ 15,423 $ 53,346 $ 56,120 $ 68,610 Less: Capital expenditures (3,029) (1,421) (720) (719) (3,210) (2,225) (4,014) Adjusted EBITDA less capital expenditures 68,355 $ 16,965 $ 20,021 $ 14,704 $ 50,136 $ 53,895 $ 64,596 Adjusted EBITDA conversion rate (8) 96 % 92 % 97 % 95 % 94 % 96 % 94 % Adjusted EBITDA margin (9) 16.7 % 15.6 % 18.6 % 15.6 % 16.0 % 17.3 %


Delaware	001-40698	38-3873146
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification Number)


13386 International Pkwy	32218
Jacksonville, Florida	(Zip Code)
(Address of principal executive offices)


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, par value $0.0001	CDRE	New York Stock Exchange


Exhibit		Description

99.1		Press Release, dated November 10, 2022 (furnished only).
99.2		Slide Presentation for Conference Call held on November 10, 2022 (furnished only).
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

	CADRE HOLDINGS, INC.


	By:	/s/ Blaine Browers
		Name:Blaine Brower
		Title:Chief Financial Officer